Health in Sierra Leone 1,333 indicators covering health for Sierra Leone. IndicatorLatest Year10-yr change Rank Under-five deaths - Current trends maintained 18,899 2030 down 15.7% 42nd Under-five deaths - SDG target met 6,521 2030 down 64.7% 54th Deaths age 10 to 19 - Remains constant 5,048 2030 up 6.1% 43rd Deaths age 10 to 19 - Current trends maintained 4,483 2030 down 3.9% 43rd Mortality caused by road traffic injury 33 per 100,000 population 2019 up 8.2% 14th Mortality caused by road traffic injury, female 23 per 100,000 female population 2019 up 4.1% 5th Mortality caused by road traffic injury, male 43.1 per 100,000 male population 2019 up 10.8% 28th Countries with birth registration data that are at least 90 percent 0 2024 — 144th Ipv vaccine coverage 91 2024 up 51.7% 109th Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2003 down 528.1% 33rd Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2003 down 528.1% 33rd Proportion of health care facilities with limited water services 15.39 2025 down 79.9% 40th Tb patients living with hiv receiving art 2,537 2021 up 902.8% 24th HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 47.1% 1st Treatment success rate for patients treated for MDR-TB 75.0% 2022 unchanged 70th New leprosy case detection rate per 1 000 000 population 13.89 2024 down 64.8% 37th Treatment success rate: HIV-positive TB cases 86 2023 up 4.9% 31st Prevalence of wasting, weight for height 6.3% 2021 down 16.0% 34th Estimated number of children (aged 0-17 years) who have lost one or 330,000 2024 down 13.2% 55th Weight-for-height <-2 SD 6.31 2021 down 15.7% 34th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 75.0% 2025 — 120th International Health Regulations core capacity scores, SPAR version 60 2025 — 64th Prevalence of underweight, weight for age 12.0% 2021 down 35.1% 38th Leprosy registered prevalence rate per 1 000 000 population 68.39 2024 up 89.3% 12th Leprosy - Number of new leprosy cases among children 9 2024 down 64.0% 36th Leprosy - Number of cases registered for treatment 591 2024 up 173.6% 21st New leprosy child case detection rate (less than 15 years of age) per 2.73 2024 down 68.6% 31st Children (0-14) living with HIV 6,500 2024 down 28.6% 27th Ipv1 number unvaccinated 21,194 2023 down 76.3% 76th Children living with hiv 6,500 2024 down 28.6% 27th Contraceptive prevalence, any method 21.2% 2019 up 158.5% 106th Children (ages 0-14) newly infected with HIV 660 2024 down 52.9% 27th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 11.3% 2024 down 39.9% 116th Number of children newly infected with hiv 660 2024 down 52.9% 27th Share of children under fifteen years old with hiv 664.7 2024 down 52.4% 27th Number of female leprosy new cases 51 2024 down 56.4% 42nd Estimated number of malaria deaths 6,646 2024 down 37.5% 23rd Estimated number of malaria cases 2.44 million 2024 down 6.6% 25th National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 — 157th Contraceptive prevalence, any modern method 20.9% 2019 up 211.9% 96th Number of prevalent tuberculosis cases 28,000 2014 up 3.7% 48th Estimated malaria incidence 282.67 2024 down 25.7% 12th Estimated malaria mortality rate 76.9 2024 down 50.3% 4th Number of new G2D leprosy cases 8 2024 down 66.7% 54th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0.926 2024 down 73.9% 48th 3.7.2 Adolescent birth rate per 1,000 women 102 2018 down 13.8% 21st 3.1.2 Proportion of births attended by skilled health personnel 87 2019 up 105.2% 125th Inflation-adjusted prices for most sold brand of cigarettes: Prices 2.34 2020 up 53.9% 164th Taxes as a % of price: total tax 22.6% 2020 up 67.4% 172nd Taxes as a % of price: value added tax 13.0% 2020 unchanged 84th Taxes as a % of price: ad valorem excise 4.3% 2020 — 98th Taxes as a % of price: specific excise 0.0% 2020 — 135th Taxes as a % of price: import duties 5.0% 2020 — 22nd Taxes as a % of price: other taxes 0.2% 2020 down 52.3% 53rd Vitamin A supplementation coverage rate 77.0% 2023 down 22.2% 23rd Inflation-adjusted prices for most sold brand of cigarettes: Price in 8,539 2020 up 41.2% 5th Estimated number of children needing antiretroviral therapy based on 6,900 2025 down 28.9% 28th Weight-for-height <-3 SD 2.36 2021 up 46.0% 11th Prevalence of severe wasting, weight for height 2.4% 2021 up 50.0% 8th ← Previous Page 17 of 23 Next →